Goldman Sachs’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Goldman Sachs’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-571	Closed	-$61.7K	–	5892
2023 Q3	$61.7K	Sell	571 -13,318	-96%	-$2.01M	﹤0.01%	5251
2023 Q2	$4.29M	Hold	13,889	–	–	﹤0.01%	3233
2023 Q1	$4.23M	Sell	13,889 -133	-0.9%	-$40.1K	﹤0.01%	3203
2022 Q4	$4.17M	Hold	14,022	–	–	﹤0.01%	3327
2022 Q3	$4.08M	Buy	14,022 +13,269	+1,762%	+$3.87M	﹤0.01%	3310
2022 Q2	$219K	Hold	753	–	–	﹤0.01%	5606
2022 Q1	$220K	Hold	753	–	–	﹤0.01%	5830
2021 Q4	$218K	Buy	753 +330	+78%	+$96.2K	﹤0.01%	5854
2021 Q3	$123K	Buy	+423	New	+$123K	﹤0.01%	5875

Other funds holding XAGE

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs's XAGE Position: Q4 2023 in Review

Goldman Sachs sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q4 2023, closing a stake of 571 shares — an estimated $61.7K sold.

Goldman Sachs first reported a position in XAGE in Q3 2021 and held it in 9 quarters. The position peaked at $4.29M in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q4 2023.

Goldman Sachs reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Goldman Sachs sold 571 Longevity Health Holdings, Inc. Common Stock shares in Q4 2023, an estimated $61.7K.
Goldman Sachs first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Goldman Sachs's Longevity Health Holdings, Inc. Common Stock position peaked at $4.29M in Q2 2023.
14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q4 2023.

Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.